While transient activation of mTORC1/mTORC2 is necessary for normal insulin action, dysregulation of these complexes promotes IR, metabolic dysfunction, and inflammation, accelerating T2D progression. The gene discussed is INS; the disease is type 2 diabetes mellitus.